DescriptionGreenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 510,000 TMS treatments to over 14,000 patients struggling with depression. The company has one reportable segment such as outpatient mental health service centers.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 8.69 +2.42% increase |
| 12.30 -27.64% decrease |
| -2.37 (-21.03%) decrease |
|3-Month|| 8.69 +2.42% increase |
| 15.30 -41.83% decrease |
| -6.24 (-41.22%) decrease |
|52-Week|| 6.65 +33.83% increase |
| 22.40 -60.27% decrease |
| +1.40 (+18.67%) increase |